| human | Q5 |
| P106 | occupation | researcher | Q1650915 |
| Q37875138 | An insight of novel pharmacological therapies in hypertrophic cardiomyopathy. |
| Q37366263 | Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis |
| Q90333541 | Bleeding Risk Prediction in Patients With Dual Antiplatelet Therapy Undergoing Coronary Artery Bypass Grafting Surgery Using a Rapid Point-of-Care Platelet Function Test |
| Q42951347 | CALU A29809G polymorphism in coronary atherothrombosis: Implications for coronary calcification and prognosis. |
| Q41139964 | CALU polymorphism A29809G affects calumenin availability involving vascular calcification |
| Q53269159 | Clinical implications of nonsarcomeric gene polymorphisms in hypertrophic cardiomyopathy. |
| Q84333966 | Collagen peptides, interstitial remodelling and sudden cardiac death in hypertrophic cardiomyopathy |
| Q85221055 | Comparative determination and monitoring of biomarkers of necrosis and myocardial remodeling between radiofrequency ablation and cryoablation |
| Q41857087 | Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation? |
| Q86863758 | Effects of Body Mass Index on the Lipid Profile and Biomarkers of Inflammation and a Fibrinolytic and Prothrombotic State |
| Q64106675 | Galectin-3 and β-trace protein concentrations are higher in clinically unaffected patients with Fabry disease |
| Q37581717 | Galectin-3 as a marker of interstitial atrial remodelling involved in atrial fibrillation. |
| Q37777419 | Genetic polymorphisms and atrial fibrillation: Insights into the prothrombotic state and thromboembolic risk |
| Q61845744 | Growth differentiation factor-15, a novel biomarker related with disease severity in patients with hypertrophic cardiomyopathy |
| Q55304633 | High-sensitivity troponin T and copeptin in non-ST acute coronary syndromes: implications for prognosis and role of hsTnT and copeptin in non-STEACS. |
| Q54690776 | High-sensitivity troponin T as a biomarker for the development of atrial fibrillation after cardiac surgery. |
| Q34735798 | Identification and confirmation of haptoglobin as a potential serum biomarker in hypertrophic cardiomyopathy using proteomic approaches |
| Q37867324 | Impact of polymorphisms in the renin-angiotensin-aldosterone system on hypertrophic cardiomyopathy |
| Q43267975 | Implications of pharmacogenetics for oral anticoagulants metabolism. |
| Q84454846 | Influence of cardiac resynchronization therapy on indices of inflammation, the prothrombotic state and tissue remodeling in systolic heart failure: a pilot study |
| Q61864728 | Inhibition of enzymes involved in collagen cross-linking reduces vascular smooth muscle cell calcification |
| Q43531407 | Interleukin-6 and high-sensitivity C-reactive protein for the prediction of outcomes in non-ST-segment elevation acute coronary syndromes |
| Q38245033 | Lone atrial fibrillation - a diagnosis of exclusion |
| Q40979707 | Long-Term Predictors of Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients Undergoing Electrical Cardioversion. |
| Q26765488 | New Approaches to the Role of Thrombin in Acute Coronary Syndromes: Quo Vadis Bivalirudin, a Direct Thrombin Inhibitor? |
| Q82904707 | Plasma levels of von Willebrand factor are increased in patients with hypertrophic cardiomyopathy |
| Q34178723 | Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients. |
| Q51306353 | Platelet reactivity over time in coronary artery disease patients treated with a bioabsorbable everolimus-eluting scaffold. |
| Q53130089 | Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation. |
| Q82636207 | Serum levels of high-sensitivity troponin T: a novel marker for cardiac remodeling in hypertrophic cardiomyopathy |
| Q39466264 | Small-size circulating microparticles in acute coronary syndromes: relevance to fibrinolytic status, reparative markers and outcomes. |
| Q47174785 | Small-size platelet microparticles trigger platelet and monocyte functionality and modulate thrombogenesis via P-selectin |
| Q84504442 | Synergism between factor XII -4C>T and factor XIII Val34Leu polymorphisms in fibrinolytic therapy in acute myocardial infarction |
| Q41669201 | TWEAK and NT-proBNP levels predict exercise capacity in hypertrophic cardiomyopathy |
| Q51202106 | The prognostic role of the adiponectin levels in atrial fibrillation. |
| Q46091960 | The prognostic value of biomarkers after a premature myocardial infarction |
| Q86697549 | Von Willebrand factor is associated with atrial fibrillation development in ischaemic patients after cardiac surgery |
Search more.